The Epstein-Barr virus (EBV)latent membrane protein (LMP)-1 is expressed in hairy leukoplakia (HL), but data on LMP-1 sequence variation of HL isolates are limited. Variation in the LMP-1 repeat region and presence of a 30-nt deletion were studied using DNA scrapings from 28 HL lesions. cDNAs from 3 different HL isolates were sequenced, 2 from lymphocyte cell lines (LCLs) generated using HL biopsy material. The deletion was found in 16 (57%) of 28 HL scrapings, and multiple repeat region variants were seen in 13 scrapings (46%). HL LMP sequences were similar to those described in nasopharyngeal cancer and lymphoma tissues, including two motifs of four amino acid changes relative to B95-8 upstream and downstream of the repeat region, respectively. Generation of LCLs using HL biopsy material confirmed the ability of HL EBV strains to infect and transform lymphocytes. The role of EBV gene products in the pathogenesis of HL with its unique histologic manifestations remains largely unknown. Of the EBV genes known to be expressed in HL, the effect of latent membrane protein (LMP)-I on epithelial cell biology has been best characterized. LMP-I inhibits epithelial cell differentiation [2] and induces epithelial hyperplasia in a transgenic mouse model [3] .
several forms of sequence variation, including differences in number of l Iv-amino acid repeat combinations [6] and deletion of 30 nt at the 3' end of the gene [6] [7] [8] .
To date, limited LMP-I sequence data from HL isolates are available, and given the unique histopathology of HL, we sought to determine if LMP-l expressed in HL differed from that of nasopharyngeal cancer or lymphoma tissues. We therefore sequenced LMP-I from an HL cDNA library and from cDNA of two different LCLs transformed by HL EBV strains. Scrapings from 28 HL lesions were further analyzed for polymorphism in the repeat region, the 30-nt deletion, and the EBV nuclear antigen (EBNA)-2 type. For comparison with the HL specimens, we also studied 6 lymphoma specimens.
Materials and Methods

Establishment of LCLs with HL EBV strains.
To establish LCLs immortalized by HL EBV strains, HL biopsy material was ground for 3 min in tubes containing 0.1 g of dry, sterile alundrum. The ground tissue mixture was suspended in 1.5 mL of RPMI 1640 with 10% fetal bovine serum and centrifuged at 2000 g. The supernatant was frozen at -80°C until inoculation. Fetal cord blood lymphocytes (10 6 cells/mL of RPMI 1640 with 10% fetal bovine serum) were mixed with an equal volume of inoculum and incubated for I h at 37°C. The cultures were monitored for 4 weeks. Two separate EBV-positive cell lines were established, each using material from a different HL biopsy.
Preparation of cDNA from LCLs and HL biopsy tissue. To prepare RNA from the LCLs for cDNA synthesis, cell pellets were suspended in 3 mL of 4.0 M guanidinium thiocyanate, 0.1 MTRIS-HCI, pH 7.5, and 1% ,6-mercaptoethanol. After homogenization and centrifugation, the RNA pellet was dissolved in 300 f.lL of TRIS-EDTA, pH 7.6. To generate cDNA, reverse transcription 5 .
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was done with LMP-I oligonucleotide primer I ( figure I ) and Moloney murine leukemia virus (MMLV) reverse transcriptase (Bethesda Research Laboratories, Gaithersburg, MD). Doublestranded eDNA was generated with 30 cycles of polymerase chain reaction (PCR) using oligonucleotide primers I and 10 (figure I), followed by nested PCR with primers 2 and II.
To generate an HL cDNA library, an HL tongue biopsy specimen was obtained from an HIV-positive patient not being treated with antiviral drugs. The tissue was homogenized in 4.0 M guanidinium thiocyanate, 0.1 M TRIS-HCI, pH 7.4, and 1% ,B-mercaptoethanol. Polyadenylated mRNA was obtained by oligo-d'I chromatography (Pharrnacia LKB Biotechnology, Piscataway, NJ). cDNA was generated with MMLV reverse transcriptase and cloned into the A. ZAP II vector using the ZAP-cDNA synthesis kit (Stratagene, La Jolla, CAl. To obtain LMP-I cDNA clones from the HL library, an aliquot was amplified by PCR as described above. PCR products were sequenced using the fmol DNA sequencing system (Promega, Madison, WI) following the manufacturer's instructions.
Amplification of 3' sequences of LMP-I. DNA was obtained from HL lesions of 28 different subjects by scraping the lesion with the blunt side of a scalpel. Scrapings were collected in 500 ilL of sample transport medium (Digene, Silver Spring, MD) and treated with proteinase K. Aliquots of 1-5 ilL of the digest were amplified with 30 cycles ofPCR using PCR primers 7 and 9 ( figure  I ). LMP-1 cDNAs from the LCLs and the HL cDNA library were also amplified, as was DNA from the M-ABA nasopharyngeal cancer strain [9] , a gift of G. Bornkamm (Institut fur Klinische Molekularbiologie und Tumorgenetik, Munich) and from 6 lymphoma specimens (provided by M. McGrath, University of California, San Francisco).
Each LMP-I gene has a characteristic pattern of II amino acid repeats, which together constitute a "repeat region unit" (RRU).
To characterize variation in the size and number of RRUs, the specimens were studied in a 30-cycle amplification reaction using oligonucleotide primers 5 and 12 (figure 1). Last, PCR-based typing of the EBNA-2 region was done as described [10] . Fisher's exact (two-sided) test was used to test for the association between the 30-nt deletion and the EBNA-2 type as well as between the deletion and detection of multiple RRUs. Specimens containing multiple forms of LMP-l with and without the deletion were excluded from statistical analysis.
Results
Establishment of LeLs with EBV strains from HI. Two
immortalized LCLs (R5-97 and R5-168) were established with material from 2 different HL biopsy specimens. The presence of EBV in the lines was confirmed by EBNA immunofluorescence and PCR amplification of different portions of the EBV genome, including LMP-l and EBNA-2. Efforts to induce productive viral infection in these cell lines were unsuccessful.
Sequence analysis ofLMP-l isolatesfrom HL strains. The
LMP-l cDNA sequences from B95-8, R5-97, and R5-168 LCLs and the HL cDNA library were determined and compared with the published sequence from B95-8 [11] and the Chinese nasopharyngeal cancer strain CAO [7] (figure 1).
Overall, the 3 HL isolates sequenced showed about the same number of nonconservative amino acid changes from the B95-8 and CAO isolates. However, all of the amino acid changes conserved among the 3 HL isolates relative to B95-8 were also found in the CAO strain, indicating that the HL isolates were genotypically closer to CAO than B95-8. Four consistent amino acid changes relative to B95-8 were found dowstream of the repeat region (positions 322, 334, 338, and 366), and four other consistent changes were found upstream of the repeat region (positions 85, 106, 129, and 212) (figure 1).
Analysis ofthe LMP-l 30-nt deletion, LMP-l repeat region,
and EBNA-2 type ofthe HL specimens. The 3' 30-nt deletion was found in 16 (57%) of28 HL scrapings, the R5-97 and R5-168 LCLs, and 3 different LMP-l clones from the HL cDNA library (table 1). Of the 6 lymphomas studied, 3 were from HIV-positive persons, and 5 were EBV-positive (table 1) . Of the latter, 1 (20%) showed the deletion.
At least two bands consistent with multiple RRUs were seen in 13 (46%) of 28 HL scrapings. All 5 of the EBV-positive lymphoma specimens showed only one RRD. Nine (64%) of 14 scraping specimens with the deletion showed multiple RRUs, whereas only 2 (17%) of 12 specimens with no deletion showed multiple RRUs (P = .02). Of the 14 specimens with the deletion, 7 contained EBNA-2 type 1. In contrast, of the 12 specimens with no deletion, 11 (92%) had EBNA-2 type 1 (P = .04). There was no clear association between number of RRUs and EBNA-2 type. All 5 EBV-positive lymphoma specimens had EBNA-2 type 1. these virions nor the range of cells they can infect have been established. In generating LeLs from HL biopsies, we demonstrated for the first time that HL tissues contain infectious EBV virions and that HL strains can transform cord blood lymphocytes. Our data also confirm the expression of LMP-l at the RNA level in HL tissues.
Our data include the most complete LMP-l sequences from HL EBV strains described to date. Since each LMP-l domain may be of functional importance, an understanding of the varying and conserved sequences of LMP-l from different EBVassociated lesions may shed light on its function in these tissues. Examination of these sequences revealed eight consistent changes relative to B95-8. The four changes found downstream of the repeat region were identical to changes previously described in nasopharyngeal cancer isolates [6, 7] and a variety of lymphoproliferative disorders [12] . Conservation of these changes across a wide variety of tissue types and pathologies suggests that they may be important in disease pathogenesis but are neither epithelium-nor lymphocyte-specific.
Several of the downstream changes may affect LMP-I phosphorylation and possibly protein function. While most potential phosphorylation sites were conserved, two, and in one case three, potential phosphorylation sites in the HL strains showed mutations. However, the same mutations were also frequent in nasopharyngeal cancer isolates [6] , suggesting that as in nasopharyngeal cancers, loss of phosphorylation at these sites is not critical to the potential transforming function of LMP-l in HL.
Four consistent amino acid changes relative to B95-8 were upstream of the repeat region of the HL strains (positions 85, 106, 129, and 212). The CAO and Raji isolates showed the same four changes, while AG876 and Cl5 showed the same changes at all but position 212. The functional significance of these changes is currently unknown.
Recently, LMP-l was shown to associate with a cellular protein, LMPI-associated protein (LAP)-l [13] . This protein interacts with the first 44 amino acids of the LMP-l carboxy terminus domain (amino acids 187-231), but the LMP-l amino acids critical to LAP-l binding have not yet been identified. Several nonconservative amino acid changes relative to B95-8 were noted in this region, including the change at residue 212, a change also found in 11 of 13 nasopharyngeal cancer isolates [6] .
Two other areas of variation were found. The first was the highly conserved 3' 30-nt deletion in about half of the HL specimens tested. This deletion has been found in lymphoma isolates as well as in nasopharyngeal cancer tumors [6] [7] [8] . The function of this IO-amino acid domain is not clear, but it is located in a region that may regulate protein turnover [14] . Since this deletion was not consistently detected in the HL strains, our data suggest that it probably does not playa direct role in the pathogenesis of HL.
A second region of variation was the repeat region, where most strains exhibited a unique combination of RRUs. Detection of multiple RRUs in the majority of HL lesions is consistent with the high levels of viral replication believed to occur in these lesions [6, 15] . In our study, EBV isolates with no LMP-l 30-nt deletion were more likely to have only one LMP RRU and to be EBNA-2 type 1. In contrast to HL specimens, most EBV-positive lymphomas show little or no viral replication. Consistent with this observation, all of the lymphoma specimens we studied showed only one RRU.
In summary, generation of LCLs with biopsy material containing HL EBV strains confirms the infectious nature of the virions within the lesion and demonstrates the ability of HL strains to infect and transform lymphocytes. LMP-l proteins from HL strains share a motif of amino acid changes relative to B95-8 with many nasopharyngeal cancer strains, and there are no data to indicate that sequence differences in HL strains account for the unique histopathology of this lesion. Further studies will be needed to assess the functional significance of the four amino acid changes upstream of the repeat region.
